Results 221 to 230 of about 42,200 (256)

Pan-cancer prevalence, risk, and clinical and demographic characteristics of Lynch Syndrome-associated variants in BioBank Japan. [PDF]

Commun Med (Lond)
Mizukami K, Usui Y, Iwasaki Y, Shiraishi K, Hirata M, Kamatani Y, Endo M, Takahashi S, Mochizuki Y, Yamaguchi M, Kohno T, Matsuda K, Sugano K, Yoshida T, Nakagawa H, Terao C, Koyanagi YN, Matsuo K, Murakami Y, Spurdle AB, Momozawa Y.   +20 more
europepmc   +1 more source

Molecular pathogenesis in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [PDF]

, 2004
Kariola, Reetta
core  

Traditional and New Views on MSI-H/dMMR Endometrial Cancer. [PDF]

Biomolecules
Liu C, Ping H, Yao M, Li X, Li Q, Hu R, Xu Y, Meng K, Gao F, Meng K.   +9 more
europepmc   +1 more source

Exploring Nectin-4 as a potential diagnostic biomarker in endometrial adenocarcinoma : Title page. [PDF]

BMC Womens Health
Ordu M, Genc SO.
europepmc   +1 more source

Assessment of mismatch repair proteins (MLH1 and MSH2) and p53 immunohistochemical expression in prostatic carcinoma: association with different clinicopathologic characteristics. [PDF]

Ecancermedicalscience
Abo Safia HS, Ghaith AF, Farghal EE, Amer BS.   +3 more
europepmc   +1 more source

Integrative proteomics reveals mitochondrial and immune signatures of MLH1 exon 13 deletion in Lynch syndrome-associated colorectal cancer. [PDF]

Front Mol Biosci
Chang C, Cao Y, Zhang B, Chen J, Chen L, Li W, Wang G.   +6 more
europepmc   +1 more source

Current surveillance in the Netherlands for urothelial carcinoma in lynch syndrome. [PDF]

Fam Cancer
Doornweerd BHJ, Kikkert RR, Koornstra JJ, van Rhijn BWG, van Gennep EJ, Langers AMJ, de Jong IJ, van Leerdam ME.   +7 more
europepmc   +1 more source

Imunohistochemická detekce MSH2 proteinu

, 2016
Černá Alena
openalex   +1 more source

Mismatch Repair Deficiency in Gliomas: A Rare Insight into Microsatellite Instability and Its Diagnostic Implications. [PDF]

Asian J Neurosurg
Rajendiran I, Ahluwalia C, Shankar KB, Arora S, Ahuja S.   +4 more
europepmc   +1 more source

MSH2 is not required for either maintenance of DNA methylation or repeat contraction at the FMR1 locus in fragile X syndrome

Jessalyn Grant-Bier, Kathryn Ruppert, Bruce E. Hayward, Karen Usdin, Daman Kumari   +4 more
openalex   +1 more source